Appointed by Governor: Joseph F. Levy, Ph.D.
Appointed by Senate President: George S. Malouf, Jr., M.D.
Appointed by House Speaker: Eberechukwu Onukwugha, Ph.D.
Appointed by Attorney General: Gerard F. Anderson
Vacancy, Executive Director
Staff: Michael J. (Ben) Steffen
c/o Maryland Health Care Commission
Maryland Department of Health
Metro Executive Office Building, 4201 Patterson Ave., Baltimore, MD 21215 - 2299
(410) 764-3565, 1-877-245-1762 (toll free)
e-mail: ben.steffen@maryland.gov
In July 2019, the Prescription Drug Affordability Board was authorized by the General Assembly (Chapter 692, Acts of 2019).
In conjunction with the Prescription Drug Affordability Stakeholder Council, the Board identifies circumstances under which the cost of a prescription drug product may create or has created affordability challenges for the State health care system and patients; and establishes criteria that the Board will use to set an upper payment limit for a prescription drug product after considering certain factors.
Appointed by Governor to 3-year terms: nine vacancies
Appointed by Senate President to 3-year terms: eight vacancies
Appointed by House Speaker to 3-year terms: eight vacancies
Organized in July 2019, the Prescription Drug Affordability Stakeholder Council serves as an advisory body to the Prescription Drug Affordability Board Chapter 692, Acts of 2019).
Twenty-five members constitute the Council. Nine are appointed by the Governor, eight by the Senate President, and eight by the House Speaker. All serve three-year terms (Chapter 692, Acts of 2019; Code Health - General Article, sec. 21-2C-04).
© Copyright Maryland State Archives